Recent Headlines
Bioo Scientific Awarded USDA Grant for Development of Technology to Detect Food Contaminants
Bioo Scientific received a SBIR Phase II award from the USDA to develop a new technology to detect contaminants in our food supply. - October 02, 2009 - Bioo Scientific
ANAVEX Contracts FORENAP Pharma for Clinical Trials of ANAVEX 2-73 in Alzheimer’s Disease
Anavex Life Sciences Corp. has selected FORENAP Pharma EURL as the contract research organization (CRO). - October 02, 2009 - Anavex Life Sciences Corp.
Bioo Scientific Offers Rapid Tests to Detect E. coli and Salmonella Contamination in Food
Bioo Scientific launched the MaxSignal® E. coli O157:H7 and Salmonella Test Strip Kits to simplify the analysis of pathogen contamination in food. - September 30, 2009 - Bioo Scientific
New HD360˚ Module Gives Clinical Trial Monitors Greater Control While Reducing Costs
Health Decisions integrates Monitor View into its HD360˚ clinical trial management system. - September 27, 2009 - Health Decisions
MedSource Hires New Associate Director of Clinical Operations
MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced today that Ms. Parisa Jabbarzadegan has joined its company as Associate Director of Clinical Operations. With more than 12 years of experience in the clinical research industry she brings a... - September 25, 2009 - MedSource
MedSource, a Contract Research Organization (CRO) Specializing in Complex Clinical Trials, Ranked No. 11 on List of Fastest Growing Companies in Houston
Companies making the Houston Business Journal’s list were ranked by percentage of revenue growth over the past two years. - September 23, 2009 - MedSource
Anavex Completes Scale-Up Manufacturing of ANAVEX 2-73 for Phase I Alzheimer’s Disease Clinical Trials
Anavex Life Sciences Corp. today announced the completion of scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer’s disease. - September 23, 2009 - Anavex Life Sciences Corp.
Cerno Bioscience’s MassWorksTM Has Proven to be 99% Accurate Software for the Identification of Unknown Compounds
MassWorks employs Cerno’s patented calibration technology to equip unit mass resolution mass spectrometers with up to 100 times more mass accuracy and unparallel Spectral Accuracy through exact isotope modeling. Through MassWorks, customers can utilize unit mass resolution mass spectrometers to identify the formulas of unknown compounds. This function, before MassWorks, was usually reserved for more expensive high resolution mass spectrometers. - September 22, 2009 - Cerno Bioscience
MedSource Named to Inc. 500/5000 List of Fastest-Growing Companies in America for the Second Time
Houston-based company ranks No. 1232 on the 2009 Inc. 5000 with three-year sales growth of 258 percent - September 08, 2009 - MedSource
Custom Adenylated Linkers Simplify miRNA Analysis
Bioo Scientific launched the AIR™ Adenylated Linkers to facilitate miRNA cloning and sequencing. - September 05, 2009 - Bioo Scientific
Stevens Faculty Assist NTSB in Hudson Mid-Air Collision Analysis
Faculty at Stevens assisted the National Transportation Safety Board and were an integral part in the analysis and recovery efforts of the Hudson Mid-Air Collision that happened on August 8th, 2009. - September 03, 2009 - Stevens Institute of Technology
Bioo Scientific Facilitates the Analysis of Melamine Contamination in Pharmaceutical Ingredients
Bioo Scientific is developing protocols to allow the MaxSignal® Melamine Test Kit to be used to screen for melamine contamination in pharmaceutical ingredients in response to the FDA’s recently released Melamine Contamination Guidance. - August 29, 2009 - Bioo Scientific
Stevens Institute of Technology Graduate Student Alicia Mahon Receives ASBPA Educational Award
Stevens Institute of Technology student Alicia Mahon has received an award from the American Shore and Beach Preservation Association for her research with a beach replenishment program. The feeder beach aims at inspiring tourism in New Jersey shores, improving surfing conditions and preventing rapid erosion of the main beach from the direct assault of waves. - August 29, 2009 - Stevens Institute of Technology
Clinical Trials in Russia. 2nd Quarter 2009
On August 24, 2009 Synergy Research Group (SynRG), a Russia-based CRO, presented the English version of SynRG Orange Paper Q2 2009, a regular analytical report on the clinical trial market in Russia. The report contains hundreds of figures as well as dozens of tables and pictures covering various... - August 27, 2009 - Synergy Research Group
Joule Biotechnologies Introduces Revolutionary Process for Producing Renewable Transportation Fuels
Two years into development, innovative startup enables path to energy independence; Unveils proprietary production system capable of supplying unlimited quantities of renewable fuel at costs competitive with fossil fuels - August 21, 2009 - Joule Biotechnologies
Caffeine Cuts Male Mating Success
New study suggests that, when long-term effects are considered, two commonly ingested stimulants are not created equal. - August 19, 2009 - Genescient Corporation
Health Decisions Contributes Adaptive Research Best Practices to Wiley’s "Clinical Trials Handbook"
CEO Michael Rosenberg authors an in-depth review of progressive research in new interdisciplinary manual - August 15, 2009 - Health Decisions
MedSource Hires New Vice President of Clinical Operations
MedSource specializes in complex diseases and study designs and has experience in more than 400 trials in Phases I-IV. - August 14, 2009 - MedSource
Bioo Scientific Awarded SBIR Grant for Development of Targeted RNAi in Vivo Delivery Technology
Bioo Scientific received a SBIR Phase II award from the NSF to develop a targeted in vivo RNAi delivery technology. - July 30, 2009 - Bioo Scientific
Sensitive Detection of Melamine Contamination
Bioo Scientific launched the MaxSignal® Melamine Enzymatic Assay Kit today which detects melamine contamination in food. - July 15, 2009 - Bioo Scientific
Sustainable Now Technologies Release Report on the History of Fuel
Sustainable Now Technologies Inc. (SNT), an alternative energies technology manufacturer, called a press conference this morning to announce the release of a new comprehensive report, titled, “The History of Fuel.” - July 11, 2009 - Sustainable Now Technologies
Sustainable Now Technologies Appoint Chief Operations Officer
Algae Bio-Reactor Manufacturer, Sustainable Now Technologies, officially recognizes Nathan Morrison as Chief of Operations. - June 27, 2009 - Sustainable Now Technologies
Anavex Appoints Dr. Hervé De Kergrohen as CEO to Lead Company Through Clinical Trials and Future Growth
Anavex Life Sciences Corp., (“ANAVEX”) (OTCBB: AVXL) today announced the immediate appointment of Hervé de Kergrohen, MD, MBA, as its Chief Executive Officer (CEO) and director. Dr. de Kergrohen is an accomplished senior executive who has successfully founded and developed... - June 18, 2009 - Anavex Life Sciences Corp.
Sustainable Now Technologies Incorporates
Sustainable Now Technologies, an alternative energies technology manufacturer, announced today the news of the company’s official incorporation. - June 10, 2009 - Sustainable Now Technologies
ENCO Pharmaceutical Development Announces Addition of Keith Hurley as Vice-President of Sales and Marketing
ENCO Pharmaceutical Development, Inc. is pleased to announce the addition of Mr. Keith Hurley to its staff as Vice-President of Sales and Marketing. - June 06, 2009 - Enco Pharmaceutical Development, Inc.
Clinical Trials in Russia. 1st Quarter 2009
On June 01, 2009 Synergy Research Group (SynRG), a Russia-based CRO, presented the English version of SynRG Orange Paper Q1 2009, a regular analytical report on the clinical trial market in Russia. The report is Free and contains hundreds of figures as well as dozens of tables and pictures covering various aspects of the Russian clinical trial market. - June 03, 2009 - Synergy Research Group
Bioo Scientific’s Toxicity Assay Kits Increase the Efficiency of Drug Development
Bioo Scientific announced the launch of the MaxDiscovery™ Toxicity Assay Kits for the monitoring of toxic effects in in vivo preclinical studies. - May 31, 2009 - Bioo Scientific
"Stress Free Nation" Campaign from Indigene Initiated in Bahrain
“Stress Free Nation” Campaign from Indigene is designed for Pharmacists and consumers and will educate them about the ways to manage high stress levels. - May 22, 2009 - Indigene Pharmaceuticals
MedSource Awarded Services Contract for a Phase I Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Clinical Trial
Houston-based Contract Research Organization (CRO) to manage three-year Phase I study - May 17, 2009 - MedSource
MedSource Awarded Services Contract for a Phase III Epilepsy Clinical Trial
MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced it has been awarded a service contract to manage a 50-center, multi-national, late phase epilepsy trial. The Houston-based CRO with regional offices in Raleigh, NC, will provide Project... - May 15, 2009 - MedSource
Sustainable Now Technologies Appoints Chief Technology Officer
At a recent press conference, Sustainable Now Technologies (SNT) announced the appointment of their third officer. - May 15, 2009 - Sustainable Now Technologies
Sustainable Now Technologies Launches Website
Green Technologies Corporation, Sustainable Now Technologies (SNT), announces the launch of it's official company website. - May 13, 2009 - Sustainable Now Technologies
Bioo Scientific Corp. Receives NIH Grant for the Development of Novel Anti-Viral Therapeutics
Bioo Scientific received a $1.25 million grant from the National Institutes of Health to develop new anti-viral therapeutics. - May 07, 2009 - Bioo Scientific
ENCO Analytix, Inc, Announces Name Change to ENCO Pharmaceutical Development, Inc.
ENCO Analytix, Inc. announced today that effective immediately the company name will change to ENCO Pharmaceutical Development, Inc. - May 03, 2009 - Enco Pharmaceutical Development, Inc.
Bioo Scientific Launches In Vivo siRNA Delivery Reagent
Bioo Scientific Developed MaxSuppressor In Vivo RNA-LANCEr II to Optimize in vivo RNAi. - May 01, 2009 - Bioo Scientific
World's Leading Scientists Meet to Examine Barriers for Stem Cell Therapies to Cure Spinal Cord Injury
Following President Barack Obama's decision to lift the ban on federal funding for embryonic stem cell research, medical and scientific experts will converge at the University of Georgia to discuss how recent advances in stem cell research can be translated into cures for spinal cord injuries. The... - March 31, 2009 - Bedford Stem Cell Research Foundation
Massachusetts Scientists Make Stem Cell Discovery
Cell Multiplication Controlled by a Surprising set of Genes. Stem cell researcher Dr. Ann Kiessling has discovered that early human embryo cells express CLOCK, and other circadian genes, that other human cells growing in laboratories did not. This was a surprise. According to Professor Jose Cibelli of Michigan State University, "This is a seminal paper. I am sure we will be referring back to it 10, 20 years from now." - March 30, 2009 - Bedford Stem Cell Research Foundation
MoBiTec GmbH, Germany, is Offering Photochromic Fluorescent Protein EosFP
The Green-to-Red switchable, photochromic Fluorescent Protein „EosFP“ offers advantageous applications in Molecular Cell Biology, and is now available through the German biotech company MoBiTec GmbH. With violet light, single cells in an EosFP marked (green) cell population can be switched to red, so that their fate can be followed selectively, for example in embryonic cell differentiation. Alternatively, a particular compartment within an EosFP marked (green) cell can be switched to red. - March 25, 2009 - MoBiTec GmbH
MoBiTec GmbH Closes Distribution Agreement for Lactococcus lactis Gene Expression System with NIZO Food Research
NIZO food research has developed a Gram positive gene expression system making use of Lactococcus lactis and its regulation mechanism for the production of the antibiotic peptide nisin, the NIsin Controlled gene Expression system (NICE). The NICE system is already used as a dedicated expression system by many labs all around the world. With NICE, MoBiTec expands its rich portfolio of non-E. coli based expression systems. - March 15, 2009 - MoBiTec GmbH
MDS Nordion to Host Physician Expert Teams from Banner Good Samaritan Medical Center and UNC School of Medicine at SIR 2009
MDS Nordion event information for the Society of Interventional Radiology 2009 Scientific Meeting. - March 07, 2009 - MDS Nordion
MDS Nordion to Demonstrate Improved TheraSphere® Administration System During SIR 2009
MDS Nordion event information for the Society of Interventional Radiology 2009 Scientific Meeting. - March 07, 2009 - MDS Nordion
Genescient and Kronos Announce Alzheimer's Disease Collaboration
Genescient Corporation and Kronos Science Laboratory will work together to analyze the Kronos Alzheimer's Case-Control Database, considered to be the finest Alzheimer's Disease genetic data set in the US. The companies hope to identify genes previously unrecognized genes that are involved in Alzheimer's Disease. - March 04, 2009 - Genescient Corporation
New Hope in Cancer Treatment for Dogs: PharmaCom BioVet’s Veterinary Oncology Treatment Centers
“We lost three of our Siberian Huskies …close family members, to cancer.” The Bertholds vowed, “We would spend the rest of our lives for the sake of our living dogs — in addition to all other dogs — attempting to find better, improved cancer treatments.” PharmaCom BioVet is truly “a union of compassion and technology.” - March 03, 2009 - PharmaCom BioVet
Anavex Appoints Leading Alzheimer's Disease Expert Dr. Mark Smith to Scientific Advisory Board
Anavex Life Sciences Corp. today announced the appointment of Dr. Mark A. Smith, Ph.D., FRCPath, to its scientific advisory board. - February 12, 2009 - Anavex Life Sciences Corp.
Clinical Trials in Russia. Year 2008.
On February 04, 2009 Synergy Research Group (SynRG), a Russia-based CRO, presented the English version of SynRG Orange Paper Year 2008, a regular analytical report on the clinical trial market in Russia. The report contains hundreds of figures as well as dozens of tables and pictures covering... - February 07, 2009 - Synergy Research Group
Anavex Scales Up Synthesis of Anavex 2-73 for Phase 1 Alzheimer’s Disease Study
Anavex Life Sciences Corp., (“ANAVEX”) (OTCBB: AVXL) has signed an agreement with organic chemistry services provider Syntagon AB (“Syntagon”) for the scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer’s disease. ANAVEX 2-73 is... - February 04, 2009 - Anavex Life Sciences Corp.
Researchers Create Smaller, Brighter Probe, Tailored for Clinical Molecular Imaging and Tumor Targeting
Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic. According to the investigators at Memorial Sloan-Kettering Cancer... - December 22, 2008 - Hybrid Silica Technologies Inc.
Ground-Breaking Anti-Amnesic and Neuroprotective Effects of Alzheimer's Compound ANAVEX 1-41 Published in Journal of Neuropsychopharmacology
Anavex Life Sciences Corp. (OTCBB: AVXL), a biopharmaceutical company engaged in the discovery and development of novel therapeutics to treat Central Nervous System (CNS) diseases and cancer, announces that the anti-amnesic and neuroprotective effects of ANAVEX 1-41 are detailed in a paper... - December 19, 2008 - Anavex Life Sciences Corp.
Anavex Presents Potent Neuroprotective Effects of Anavex 1-41 at Neuroscience 2008
Anavex Life Sciences Corp., a biopharmaceutical company engaged in the discovery and development of novel therapeutics to treat Central Nervous System (CNS) diseases and cancer, was selected to present its latest results with ANAVEX 1-41 at Neuroscience 2008, the 38th annual meeting of the Society... - December 17, 2008 - Anavex Life Sciences Corp.
GeneThera Will Test Raw and Processed Milk for Johne’s Disease Due to Evidence Linking Johne’s Disease to Irritable Bowel Syndrome (IBS) and Chron’s Disease
GeneThera will test raw and processed milk for Johne’s disease due to evidence linking Johne’s disease to Irritable Bowel Syndrome (IBS) and Chron’s disease starting January, 2009. GeneThera, Inc. (GTHR.PK), GeneThera announces it will soon begin testing of raw and processed milk... - December 10, 2008 - GeneThera Inc.